Drug Side Effects
Search
CUTANEOUS T-CELL LYMPHOMA STAGE IV
CUTANEOUS T-CELL LYMPHOMA STAGE IV
was reported 36 times
These drug classes are most commonly taken by patients reporting CUTANEOUS T-CELL LYMPHOMA STAGE IV:
#
Drug
Count
0
Interleukin-4 Receptor alpha Antagonist [EPC]
24
1
Janus Kinase Inhibitor [EPC]
5
2
Folate Analog Metabolic Inhibitor [EPC]
3
3
Interferon alpha [EPC]
3
4
Retinoid [EPC]
3
5
Alkylating Drug [EPC]
2
6
Corticosteroid [EPC]
2
7
Tumor Necrosis Factor Blocker [EPC]
2
8
Angiotensin Converting Enzyme Inhibitor [EPC]
1
9
Arteriolar Vasodilator [EPC]
1
10
CD20-directed Cytolytic Antibody [EPC]
1
11
Dietary Cholesterol Absorption Inhibitor [EPC]
1
12
HMG-CoA Reductase Inhibitor [EPC]
1
13
Histamine-1 Receptor Antagonist [EPC]
1
14
Human Immunoglobulin G [EPC]
1
15
Interleukin-17A Antagonist [EPC]
1
16
Vitamin B12 [EPC]
1
17
Vitamin C [EPC]
1
18
Vitamin D [EPC]
1
19
Xanthine Oxidase Inhibitor [EPC]
1